94 related articles for article (PubMed ID: 15680906)
1. 15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells.
Tong M; Tai HH
Arch Biochem Biophys; 2005 Mar; 435(1):50-5. PubMed ID: 15680906
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
Tong M; Ding Y; Tai HH
Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors and transforming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells.
Tong M; Ding Y; Tai HH
Biochem Pharmacol; 2006 Sep; 72(6):701-9. PubMed ID: 16844092
[TBL] [Abstract][Full Text] [Related]
4. Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells.
Tong M; Tai HH
Biochem Biophys Res Commun; 2000 Sep; 276(1):77-81. PubMed ID: 11006085
[TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
[TBL] [Abstract][Full Text] [Related]
6. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
Ding Y; Tong M; Liu S; Moscow JA; Tai HH
Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
[TBL] [Abstract][Full Text] [Related]
7. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
8. Characterization of corticosteroid redosing in an in vitro cell line model.
Vidaeff AC; Ramin SM; Gilstrap LC; Alcorn JL
Am J Obstet Gynecol; 2004 Oct; 191(4):1403-8. PubMed ID: 15507973
[TBL] [Abstract][Full Text] [Related]
9. The effects of dexamethasone and betamethasone on surfactant protein-B messenger RNA expression in human type II pneumocytes and human lung adenocarcinoma cells.
Ramin SM; Vidaeff AC; Gilstrap LC; Bishop KD; Jenkins GN; Alcorn JL
Am J Obstet Gynecol; 2004 Apr; 190(4):952-9. PubMed ID: 15118620
[TBL] [Abstract][Full Text] [Related]
10. Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.
Li M; Xie J; Cheng L; Chang B; Wang Y; Lan X; Zhang D; Yin Y; Cheng N
Cancer Invest; 2008 Nov; 26(9):905-12. PubMed ID: 19034772
[TBL] [Abstract][Full Text] [Related]
11. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.
Chi X; Freeman BM; Tong M; Zhao Y; Tai HH
Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039
[TBL] [Abstract][Full Text] [Related]
12. Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.
Liu Z; Wang X; Lu Y; Han S; Zhang F; Zhai H; Lei T; Liang J; Wang J; Wu K; Fan D
Carcinogenesis; 2008 Jun; 29(6):1219-27. PubMed ID: 18174234
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone inhibits the induction of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase by phorbol ester in human promonocytic U937 cells.
Tong M; Tai HH
Biochim Biophys Acta; 2000 Jun; 1497(1):61-8. PubMed ID: 10838159
[TBL] [Abstract][Full Text] [Related]
14. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.
Tai HH; Tong M; Ding Y
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):203-8. PubMed ID: 17481556
[TBL] [Abstract][Full Text] [Related]
15. An unexpected effect of glucocorticoids on stimulation of c-fms proto-oncogene expression in choriocarcinoma cells that express little glucocorticoid receptor.
Chambers SK; Ivins CM; Kacinski BM; Hochberg RB
Am J Obstet Gynecol; 2004 Apr; 190(4):974-85. PubMed ID: 15118624
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.
Wakimoto N; Wolf I; Yin D; O'Kelly J; Akagi T; Abramovitz L; Black KL; Tai HH; Koeffler HP
Cancer Res; 2008 Sep; 68(17):6978-86. PubMed ID: 18757412
[TBL] [Abstract][Full Text] [Related]
17. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
[TBL] [Abstract][Full Text] [Related]
18. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy.
Na HK; Park JM; Lee HG; Lee HN; Myung SJ; Surh YJ
Biochem Pharmacol; 2011 Nov; 82(10):1352-60. PubMed ID: 21856294
[TBL] [Abstract][Full Text] [Related]
19. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
Tai HH; Chi X; Tong M
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
[TBL] [Abstract][Full Text] [Related]
20. Induction of human sulfotransferase 1A3 (SULT1A3) by glucocorticoids.
Bian HS; Ngo SY; Tan W; Wong CH; Boelsterli UA; Tan TM
Life Sci; 2007 Dec; 81(25-26):1659-67. PubMed ID: 17963788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]